Treatment options in patients with pancreatic cancer: A 10-year multicenter epidemiological investigation in China

Table 2 Treatments options for patients with pancreatic cancer in China from 2005 to 2014

Treatment modalities		Cases	%
Surgery
Mode of operation
	Radical	1059	49.67
	Palliative	576	27.02
	Other	497	23.31
Mode of execution
	Traditional open surgery	2073	91.85
	Laparoscopic surgery	63	2.79
	Robotic surgery	3	0.13
	Other	118	5.23
Chemotherapy
	Neoadjuvant	90	8.36
	Adjuvant therapy	382	35.50
	Relapse/metastasis treatment	604	56.13
Targeted therapy information
	Neoadjuvant	2	2.60
	Adjuvant therapy	39	51.30
	Relapsing metastasis therapy	35	46.00
Radiation therapy information
	Concurrent	36	16.82
	Postoperative adjuvant	75	35.05
	Palliative	137	64.02
	Intraoperative	83	38.79
	Other	31	14.49

Drug statistics of chemotherapy include single drug and combination drug.